DGAP-News: Burcon NutraScience Corp.: BURCON FILES NASDAQ LISTING APPLICATION
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): IPO
Burcon NutraScience Corp.: BURCON FILES NASDAQ LISTING APPLICATION
02.09.2011 / 07:34
---------------------------------------------------------------------
BURCON FILES NASDAQ LISTING APPLICATION
Vancouver, British Columbia, September 1, 2011- Burcon NutraScience
Corporation (TSX - BU) ('Burcon' or the 'Company') is pleased to announce
that it has filed an application to list its common shares on the NASDAQ
Stock Market LLC and has filed a registration statement to register its
common shares on Form 40-F with the United States Securities and Exchange
Commission (the 'SEC'), pursuant to section 12 of the United States
Securities Exchange Act of 1934.
Listing of the Company's common shares on NASDAQ is subject to receipt of
all necessary regulatory approvals, including NASDAQ and the SEC and is
expected to take until the end of September or mid October 2011. In
connection with the filing of its Form 40-F, the Company has filed on SEDAR
its 2011 consolidated financial statements prepared in accordance with
International Financial Reporting Standards.
'This listing is a natural evolution for our company,' said Johann F.
Tergesen, president and COO of Burcon, adding 'Under the previously
announced CLARISOY(R) soy license agreement, Archer Daniels Midland
Company, our US-based partner, has an exclusive and global license for the
production, distribution and sale of CLARISOY(R) across all geographic
regions and all product uses and we expect initial commercial sales of
CLARISOY(R) by ADM will be in the United States. Having our shares traded
on NASDAQ will make it easier for investors in the United States to invest
in Burcon thus increasing our liquidity and addressing demand for our
shares from investors south of the border. This listing will not involve
any money raise or issuance of shares from treasury.'
Burcon also reports that we have recently received notice from the United
States Patent and Trademark Office that two of our U.S. patent applications
have now proceeded to grant as United States patents. The first U.S. Patent
- titled 'Canola Protein Isolate Functionality II' (US Patent No.
7,989,017) covers functional applications of blends of Burcon's canola
protein isolates Puratein(R) and Supertein(TM) in food and beverage
products. The second U.S. Patent - titled 'Canola Protein Isolate' (US
Patent No. 7,981,450) covers extraction procedures that improve the quality
and purity of Supertein(TM) canola protein isolate.
'We have been encouraged by recent transactions in the general intellectual
property markets,' said Johann F. Tergesen, president and COO of Burcon,
adding 'Strategic buyers have been recognizing the value inherent in a
patent portfolio's ability to protect a product's market.
We have seen increased interest from a variety of participants in our
market place in all aspects of our products and our patents. Burcon's
business strategy has been to develop a sound patent portfolio that broadly
protects our core inventions. In general we have sought to protect our
processing technologies, the functional applications of our novel proteins
as they may be used in end products, and also to protect the signature
characteristics of the proteins themselves. To-date, our patent portfolio
consists of 170 issued patents in various countries, including 29 issued
U.S. patents, and in excess of 300additional pending patent applications,
72 of which are U.S. patent applications.'
About Burcon NutraScience
Burcon is a leader in nutrition, health and wellness in the field of
functional, renewable plant proteins. Since 1999, Burcon has developed a
portfolio of composition, application, and process patents originating from
our core protein extraction and purification technology. We are developing
Puratein(R) and Supertein(TM) canola protein isolates with unique
functional and nutritional attributes, and CLARISOY(R), a revolutionary soy
protein isolate which is 100% soluble and completely transparent in low pH
solutions. Our team of highly specialized scientists and engineers work
from our private research facility to develop and optimize environmentally
sound technologies. To-date, our patent portfolio consists of 170 issued
patents in various countries, including 29 issued U.S. patents, and in
excess of 300 additional pending patent applications, 72 of which are U.S.
patent applications.
###
ON BEHALF OF THE BOARD OF DIRECTORS
'Johann F. Tergesen'
Johann F. Tergesen
President and Chief Operating Officer
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements that involve risks and
uncertainties. These forward-looking statements relate to, among other
things, plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development or reliance on our development partner. When used
in this press release, the words 'goal', 'intend', 'believes' and
'potential' and similar expressions, generally identify forward-looking
statements. These statements reflect our current expectations. They are
subject to a number of risks and uncertainties.
For more information, please contact:
Jade Cheng, Chief Financial Officer
Burcon NutraScience Corporation
(604) 733-0896 / (888) 408-7960 toll-free
jcheng(at)burcon.ca www.burcon.ca
End of Corporate News
---------------------------------------------------------------------
02.09.2011 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
138036 02.09.2011
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 02.09.2011 - 07:34 Uhr
Sprache: Deutsch
News-ID 61861
Anzahl Zeichen: 8732
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 184 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: BURCON FILES NASDAQ LISTING APPLICATION"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
